Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Industry warns ISS reductions and launch-capacity limits could slow U.S. microgravity biotech and commercial LEO transition
Summary
Witnesses told senators that proposed program cuts and launch infrastructure constraints risked reducing U.S. crew on the ISS and stalling microgravity manufacturing gains; Redwire highlighted medical and pharmaceutical research aboard the station.
Industry witnesses and former NASA officials told the Senate Commerce Committee that continued operations in low Earth orbit (LEO) and predictable funding are critical to sustain emerging commercial microgravity industries. Michael Gold of Redwire said that without the funding and directive of recent congressional action, "we run the risk of reducing the number of American astronauts on the ISS from 4 to 3, and then down to 2." He added that such…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
